Vaxivax, the manufacturer of the Coronavivirus vaccine, said Thursday that it has received the first two doses of the vaccine.
It said it expects to complete manufacturing and distribution of the vaccines by mid-April.
Vaxivac has been a cornerstone of President Donald Trump’s healthcare agenda, a goal that was echoed by his Vice President Mike Pence during a visit to the state of Massachusetts this week.
Vaccines, vaccines, vaccines.
If it works, great, if it doesn’t it’s a failure, Pence said.
Vox told Bloomberg the two doses were “very well-received.”
The company said it is working to ensure the remaining doses will be delivered by the end of March.
Vaxac has not yet announced a timetable for the second dose.
The U.S. is set to become the first nation in the world to get its own vaccine to combat coronavirus.
The first shots are expected to be distributed this summer in Oregon, Utah and Washington.
Vicki Anderson, the executive director of the National Vaccine Information Center, which provides information about vaccine-preventable diseases, said the rollout of Coronacavirus vaccines is a “historic moment” in the U.K.
A vaccine supply chain.
Anderson said the U to be the first to get their own vaccine, which would be followed by other countries.
“Vax is not just an industry, it’s an industry and the vaccine is going to be in everybody’s hands,” Anderson said.
“And it’s going to become a global market and it’s something that’s been anticipated.”
VaxiNews reporter Emily Dickson contributed to this report.